Masao Tsujihata

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Lewy body–type degeneration in cardiac plexus in Parkinson’s and incidental Lewy body diseases

Ken Iwanaga, Koichi Wakabayashi, Makoto Yoshimoto et al. · Neurology · 1999 · 273 citations

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Thomas Powles, Piotr Tomczak, Se Hoon Park et al. · The Lancet Oncology · 2022 · 262 citations · Full text

Pure akinesia: an atypical manifestation of progressive supranuclear palsy.

Hidenori Matsuo, Hisayuki TAKASHIMA, Masazumi Kishikawa et al. · Journal of Neurology Neurosurgery & Psychiatry · 1991 · 91 citations · Full text

Ophthalmology, Corticobasal Degeneration, Neuroanatomy +12

Laparoscopic Radical Nephroureterectomy: A Multicenter Analysis in Japan

Osamu Kamihira, Ryohei Hattori, Akito Yamaguchi et al. · European Urology · 2009 · 91 citations

Laparoscopic Radical Nephroureterectomy, Laparoscopy, Urology +5